Skip to main content
MJFF Feed

The New York Times Essay Spotlights Parkinson’s Patients’ Biology and Optimism

The New York Times Essay Spotlights Parkinson’s Patients’ Biology and Optimism

Readers of this weekend’s New York Times were met with a lesson in Parkinson’s as told by friend of MJFF Jon Palfreman, who was diagnosed four years ago. While labeled an opinion piece, Palfreman’s essay is packed with facts on the experience of the disease and its biological underpinnings:

Bad signals disrupt communication between the brain and the muscles. This is one reason people with Parkinson’s have trouble picking up small objects and moving around fluently: Their motions are too hesitant, too small, too slow, too rigid, too shaky, too feeble and badly timed. These are symptoms of a brain in conflict with itself ...

... Here’s the theory scientists have come up with: Sometimes good proteins go bad. For multiple reasons (like genes, environment and age) proteins can “misfold” and stick to other proteins. When proteins do this, they can become toxic.

He discusses the promise of research and the optimism of people living with Parkinson’s today:

Some researchers foresee the possibility that one day in the not too distant future they may be able to develop drugs to target these rogue proteins ... Parkinson’s patients like me take comfort from the idea that our insights can help unpack these diseases and assist in the scientific pursuit of better therapies and ultimate cures.

Palfreman is co-author of “The Case of the Frozen Addicts,” detailing the onset of Parkinson’s symptoms among a small group of drug users. He is also a professor of broadcast journalism at the University of Oregon and the author of the forthcoming book “Brain Storms: The Race to Unlock the Mysteries of Parkinson’s Disease.” Stay tuned for more on that publication.

Read Palfreman’s full New York Times piece.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.